Performance of Immunoassays for CA 19-9, CA 15-3 and CA 125 Tumour Markers Evaluated from an International Quality Assessment Survey

@inproceedings{Pilo1996PerformanceOI,
  title={Performance of Immunoassays for CA 19-9, CA 15-3 and CA 125 Tumour Markers Evaluated from an International Quality Assessment Survey},
  author={Alessandro Pilo and Gian Carlo Zucchelli and Rob Cohen and Massimo Chiesa and Ch. A. Bizollon},
  booktitle={European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies},
  year={1996}
}
Data collected in the 1993 and 1994 cycles of an international External Quality Assessment (EQA) programme were cumulatively analysed to evaluate the analytical performance of the methods currently in use for routine assay of mucinous tumour markers CA 19-9, CA 15-3 and CA 125. On average the between-laboratory variability was 14.7 and 15.8 CV% for CA 15-3 and CA 125 respectively. For CA 19-9, a markedly worse between-laboratory variability (on average 27.2 CV%) was found; the agreement of CA… CONTINUE READING

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

A new concept for quality control of clinical laboratory investigation in the light of clinical requirements and based on reference methods

D Stamm
  • Eur J Clin Chem Clin Biochem
  • 1992

Clinical review 12: The use and misuse of the sensitive thyrotropin assays.

  • The Journal of clinical endocrinology and metabolism
  • 1990
VIEW 3 EXCERPTS